Pierantonio Menna Selected Research

Oxidoreductases (Dehydrogenase)

1/2022

Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN).

2/2007

Defective taxane stimulation of epirubicinol formation in the human heart: insight into the cardiac tolerability of epirubicin-taxane chemotherapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierantonio Menna Research Topics

Disease

30	Cardiotoxicity 12/2023 - 09/2002
19	Neoplasms (Cancer) 05/2022 - 06/2004
9	Heart Failure 01/2022 - 06/2004
6	Cardiomyopathies (Cardiomyopathy) 01/2022 - 06/2003
4	Infections 05/2022 - 08/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 07/2010
3	Breast Neoplasms (Breast Cancer) 11/2020 - 01/2017
2	Seizures (Absence Seizure) 02/2024 - 10/2022
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 05/2022
2	Mycoses (Diseases, Fungus) 05/2022 - 01/2021
2	Leukemia 05/2022 - 01/2022
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 01/2018
2	Tachycardia (Tachyarrhythmias) 01/2019 - 12/2018
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016 - 02/2013
1	Invasive Fungal Infections 10/2023
1	Neutropenia 10/2023
1	Cardiac Arrhythmias (Arrythmia) 01/2023
1	Atrial Fibrillation 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2023
1	Ventricular Tachycardia 01/2023
1	Febrile Neutropenia 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Systolic Heart Failure 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020
1	Philadelphia Chromosome 01/2020
1	Anemia 01/2019
1	Necrosis 12/2018
1	Mucormycosis 01/2018
1	Aspergillosis 01/2018

Drug/Important Bio-Agent (IBA)

34	AnthracyclinesIBA 12/2023 - 09/2002
21	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 09/2002
6	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2012 - 04/2006
5	Epirubicin (Ellence)FDA LinkGeneric 05/2012 - 06/2004
5	quinone (benzoquinone)IBA 01/2010 - 01/2004
4	midostaurinIBA 10/2023 - 01/2021
4	Antineoplastic Agents (Antineoplastics)IBA 05/2012 - 06/2004
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2018
3	Trastuzumab (Herceptin)FDA Link 04/2019 - 05/2008
3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2013 - 06/2009
3	adriamycinolIBA 02/2013 - 07/2006
3	hydroquinone (Esoterica)FDA Link 01/2010 - 01/2008
3	IronIBA 01/2008 - 01/2004
2	CenobamateIBA 02/2024 - 10/2022
2	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2018
2	Ranolazine FDA Link 01/2022 - 01/2019
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 11/2020
2	Oxidoreductases (Dehydrogenase)IBA 01/2022 - 02/2007
2	pixantrone (BBR 2778)IBA 01/2016 - 02/2013
2	AnthraquinonesIBA 01/2016 - 02/2013
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2016 - 02/2013
2	Superoxides (Superoxide)IBA 02/2013 - 05/2012
2	AntioxidantsIBA 01/2010 - 09/2002
2	Free RadicalsIBA 01/2008 - 06/2004
2	Docetaxel (Taxotere)FDA Link 02/2007 - 07/2006
2	taxaneIBA 02/2007 - 07/2006
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2007 - 07/2006
2	ferrylmyoglobinIBA 02/2004 - 09/2002
1	posaconazole FDA Link 10/2023
1	Micafungin (FK463)FDA Link 10/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023
1	ibrutinibIBA 01/2023
1	isocitric acid (isocitrate)IBA 01/2022
1	Inotuzumab OzogamicinIBA 01/2022
1	olutasidenibIBA 01/2022
1	enasidenibIBA 01/2022
1	ivosidenibIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 01/2022
1	quizartinibIBA 01/2022
1	SodiumIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Phosphodiesterase InhibitorsIBA 01/2022
1	venetoclaxIBA 01/2022
1	glasdegibIBA 01/2022
1	Gemtuzumab (Mylotarg)FDA Link 01/2022
1	gilteritinibIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	ponatinibIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2019
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Cardiovascular AgentsIBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	TroponinIBA 12/2018
1	Troponin IIBA 12/2018
1	Protein Isoforms (Isoforms)IBA 12/2018
1	Hormones (Hormone)IBA 12/2018
1	Colistin (Coly-Mycin)FDA Link 01/2018
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2018
1	AntiemeticsIBA 01/2018
1	isavuconazoleIBA 01/2018
1	TriazolesIBA 01/2018

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 10/2023 - 07/2006
11	Therapeutics 11/2020 - 04/2006
3	Drug Tapering 01/2023 - 07/2010
2	Transplantation 05/2022 - 01/2022
2	Biological Therapy 05/2022 - 01/2022
1	Continuous Renal Replacement Therapy 01/2018